Search research articles
Contact Us
Filters
Showing results (671-680 of 749) with videos related to
Page
of 75
Sort By:
JAMA Surgery
|
September 6, 2023
Opioid-Free Discharge After Pancreatic Resection Through a Learning Health System Paradigm
Artem Boyev, Anish J Jain, Timothy E Newhook, et al.
Annals of Surgical Oncology
|
June 28, 2019
Inpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients
Timothy E Newhook, Whitney L Dewhurst, Timothy J Vreeland, et al.
Integrative Cancer Therapies
|
December 21, 2019
Home-Based Exercise Prehabilitation During Preoperative Treatment for Pancreatic Cancer Is Associated With Improvement in Physical Function and Quality of Life
An Ngo-Huang, Nathan H Parker, Eduardo Bruera, et al.
Cancer Cell
|
June 6, 2022
Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer
Emma Kurz, Carolina Alcantara Hirsch, Tanner Dalton, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
December 13, 2017
Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy
Jordan M Cloyd, Graciela M Nogueras-González, Laura R Prakash, et al.
JAMA Oncology
|
July 14, 2022
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial
Matthew H G Katz, Qian Shi, Jeff Meyers, et al.
Annals of Surgical Oncology
|
October 17, 2018
First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
Pat Gulhati, Laura Prakash, Matthew H G Katz, et al.
Journal of Surgical Oncology
|
August 16, 2021
Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapy
Timothy E Newhook, Laura R Prakash, Jose Soliz, et al.
Journal of Physical Activity & Health
|
October 9, 2019
Supports and Barriers to Home-Based Physical Activity During Preoperative Treatment of Pancreatic Cancer: A Mixed-Methods Study
Nathan H Parker, Rebecca E Lee, Daniel P O'Connor, et al.
Annals of Surgical Oncology
|
February 18, 2010
Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation
Matthew H G Katz, Gauri R Varadhachary, Jason B Fleming, et al.
Page
of 75
Search research articles
Search
Showing results (671-680 of 749) with videos related to
Sort By:
Page
of 75
JAMA Surgery
|
September 6, 2023
Opioid-Free Discharge After Pancreatic Resection Through a Learning Health System Paradigm
Artem Boyev, Anish J Jain, Timothy E Newhook, et al.
Annals of Surgical Oncology
|
June 28, 2019
Inpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients
Timothy E Newhook, Whitney L Dewhurst, Timothy J Vreeland, et al.
Integrative Cancer Therapies
|
December 21, 2019
Home-Based Exercise Prehabilitation During Preoperative Treatment for Pancreatic Cancer Is Associated With Improvement in Physical Function and Quality of Life
An Ngo-Huang, Nathan H Parker, Eduardo Bruera, et al.
Cancer Cell
|
June 6, 2022
Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer
Emma Kurz, Carolina Alcantara Hirsch, Tanner Dalton, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
December 13, 2017
Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy
Jordan M Cloyd, Graciela M Nogueras-González, Laura R Prakash, et al.
JAMA Oncology
|
July 14, 2022
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial
Matthew H G Katz, Qian Shi, Jeff Meyers, et al.
Annals of Surgical Oncology
|
October 17, 2018
First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
Pat Gulhati, Laura Prakash, Matthew H G Katz, et al.
Journal of Surgical Oncology
|
August 16, 2021
Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapy
Timothy E Newhook, Laura R Prakash, Jose Soliz, et al.
Journal of Physical Activity & Health
|
October 9, 2019
Supports and Barriers to Home-Based Physical Activity During Preoperative Treatment of Pancreatic Cancer: A Mixed-Methods Study
Nathan H Parker, Rebecca E Lee, Daniel P O'Connor, et al.
Annals of Surgical Oncology
|
February 18, 2010
Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation
Matthew H G Katz, Gauri R Varadhachary, Jason B Fleming, et al.
Page
of 75